Skip to main content
. 2014 May;234(1):154–161. doi: 10.1016/j.atherosclerosis.2014.02.014

Table 1.

EC50 and Emax values for ONOO-induced relaxations.

EC50 (M) Change in EC50 (M) (compared to control) Emax(%) Change in Emax( %) (compared to control)
C57/BL-6 Control 3.9 × 10−5 (CI: 3.2–4.8 × 10−5) N/A 87.8 (SEM: 4.7) N/A
3 μM TG 4.9 × 10−5 (CI: 3.5–6.9 × 10−5) +1.0 × 10−5 22.3 (SEM: 4.3) −65.6
10 μM CE 3.4 × 10−5 (CI: 2.1–5.5 × 10−5) −0.5 × 10−5 97.5 (SEM: 9.1) +9.6
2mo hfd ApoE−/− Control 1.9 × 10−5 (CI: 1.6–2.3 × 10−5) N/A 89.6 (SEM: 2.9) N/A
3 μM TG 8.5 × 10−5 (CI: 6.8–10.6 × 10−5) +6.6 × 10−5 83.6 (SEM: 4.9) −6.6
10 μM CE 4.6 × 10−5 (CI: 2.8–7.8 × 10−5) +2.7 × 10−5 82.6 (SEM: 9.5) −7.0
4mo hfd ApoE−/− Control 3.3 × 10−5 (CI: 2.7–3.9 × 10−5) N/A 82.5 (SEM: 3.7) N/A
3 μM TG No relaxation No relaxation No relaxation No relaxation
10 μM CE 2.5 × 10−5 (CI: 1.9–3.3 × 10−5) −0.8 × 10−5 82.2 (SEM: 4.0) −0.2